Visual Outcomes After Early Vitreous Surgery for Aggressive Posterior Retinopathy of Prematurity

被引:13
作者
Azuma, Noriyuki
Ito, Makiko
Yokoi, Tadashi
Nakayama, Yuri
Nishina, Sachiko
机构
[1] Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Tokyo 1578535, Japan
[2] Natl Ctr Child Hlth & Dev, Cell Biol Lab, Tokyo 1578535, Japan
关键词
LENS-SPARING VITRECTOMY; RETINAL-DETACHMENT; INTRAVITREAL BEVACIZUMAB; RISK-FACTORS; INJECTION; INFANTS; EFFICACY;
D O I
10.1001/jamaophthalmol.2013.4148
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
IMPORTANCE Aggressive posterior retinopathy of prematurity (AP-ROP) rapidly progresses to retinal detachment despite application of photocoagulation. Early vitreous surgery might achieve prompt regression of neovascular activity and a high incidence of retinal reattachment. OBJECTIVE To evaluate visual outcomes in eyes with AP-ROP after early vitreous surgery. DESIGN Retrospective nonrandomized study of patients who underwent early vitreous surgery with lensectomy when retinal detachment developed despite photocoagulation. Aphakic correction with spectacles or contact lenses and the use of orthoptics were continued postoperatively. The best-corrected visual acuity (VA) was measured in eyes with a total retinal reattachment using the preferential looking technique in patients ranging in age from 8 months to no more than 3 years and a VA chart with Landolt rings or pictures for older children. The VA findings were converted to Snellen lines. SETTING Institutional ophthalmology practice. PARTICIPANTS Of the 103 eyes (57 patients) that underwent early vitreous surgery for AP-ROP, the VA was measured in 58 (32 patients) at a corrected age ranging from 8 months to 4 years. INTERVENTIONS Early vitreous surgery and VA measurement using the preferential looking technique and a VA chart. MAIN OUTCOMES AND MEASURES Postoperative VA, ROP stage, extent of fibrovascular tissue (FT) growth, and laterality of the eyes that underwent surgery. RESULTS The VAs ranged from 20/2000 to 20/40. The VA may not be related to the preoperative ROP stage 4A or 4B but may depend on the preoperative extent of FT growth. In 39 of 58 eyes (67.2%), the FT had not reached the vitreous base preoperatively, and foveal formation occurred postoperatively with nearly age-appropriate VA (range, 20/250 to 20/40). In 17 of 58 eyes (29.3%), the FT had reached the vitreous base, and no fovea formed (VA range, 20/2000 to 20/250). Two of 58 eyes (3.4%) had deprivation amblyopia with a VA worse than 20/1600. The difference in VA between both eyes of patients who underwent bilateral vitreous surgery depended on ROP progression; patients who underwent a unilateral procedure in which the fellow eyes with ROP stabilized after photocoagulation tended to have poor vision because of deprivation amblyopia. CONCLUSIONS AND RELEVANCE Early vitreous surgery may be beneficial for AP-ROP and should be performed before the FT reaches the vitreous base to facilitate foveal formation and good VA outcomes. The roles of photocoagulation, vitreous surgery, and anti-vascular endothelial growth factor therapy in the treatment of AP-ROP should be investigated in randomized trials regarding efficacy, safety, convenience, and cost.
引用
收藏
页码:1309 / 1313
页数:5
相关论文
共 23 条
[1]   Early vitreous surgery for aggressive posterior retinopathy of prematurity [J].
Azuma, Noriyuki ;
Ishikawa, Kaoru ;
Hama, Yukiko ;
Hiraoka, Miina ;
Suzuki, Yumi ;
Nishina, Sachiko .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (04) :636-643
[2]  
Barishak YR, 2001, EMBRYOLOGY EYE ITS A, P105
[3]  
Drenser Kimberly A, 2010, Retina, V30, pS37, DOI 10.1097/IAE.0b013e3181cb6151
[4]   Three-port lens-sparing vitrectomy for aggressive posterior retinopathy of prematurity: Early surgery before tractional retinal detachment appearance [J].
Ferrari, T. Micelli ;
Furino, C. ;
Lorusso, V. V. ;
Dammacco, R. ;
Sborgia, G. ;
Sborgia, L. ;
Besozzi, G. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (05) :785-789
[5]   The international classification of retinopathy of prematurity revisited [J].
Gole, GA ;
Ells, AL ;
Katz, X ;
Holmstrom, G ;
Fielder, AR ;
Capone, A ;
Flynn, JT ;
Good, WG ;
Holmes, JM ;
McNamara, JA ;
Palmer, EA ;
Quinn, GE ;
Shapiro, MJ ;
Trese, MGJ ;
Wallace, DK .
ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (07) :991-999
[6]  
GWIAZDA J, 1980, AM J OPTOM PHYS OPT, V57, P420
[7]  
Hiraoka Miina, 2004, Nippon Ganka Gakkai Zasshi, V108, P600
[8]   Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity [J].
Honda, Shigeru ;
Hirabayashi, Hiroaki ;
Tsukahara, Yasutomo ;
Negi, Akira .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (07) :1061-1063
[9]   Reactivation of Retinopathy of Prematurity After Bevacizumab Injection [J].
Hu, Jennifer ;
Blair, Michael P. ;
Shapiro, Michael J. ;
Lichtenstein, Steven J. ;
Galasso, John M. ;
Kapur, Rashmi .
ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (08) :1000-1006
[10]  
Katsumi O, 1983, JPN J CLIN OPHTHAL, V37, P965